| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/06/2013 | CN102949571A Medicine for treating chronic osteomyelitis |
| 03/06/2013 | CN102949556A Traditional Chinese medicine preparation for treating arthropathy |
| 03/06/2013 | CN102949510A Preparation method of externally-applied medicinal wine for rheumatisms |
| 03/06/2013 | CN102949508A Group of hot ironing muscle relaxing powder |
| 03/06/2013 | CN102949505A Traditional Chinese medicinal wine |
| 03/06/2013 | CN102949476A Health traditional Chinese medicine composition for heel pain |
| 03/06/2013 | CN102949475A Preparation method of health care medicament |
| 03/06/2013 | CN102949465A Traditional Chinese medicine used for treating traumatic injury |
| 03/06/2013 | CN102949448A Dipsacus asperoides powder capsule |
| 03/06/2013 | CN102949445A Pure traditional Chinese medicine preparation for activating blood circulation to dissipate stasis and preparation method thereof |
| 03/06/2013 | CN102949434A Purpose of bitter marrow squash extracts in anti-gout medicine preparation |
| 03/06/2013 | CN102949404A Application of vanillic acid glucoside derivative in treatment of systemic autoimmune disease |
| 03/06/2013 | CN102949403A Celecoxib composition, and preparation method and application thereof |
| 03/06/2013 | CN102949402A Celecoxib composition, and preparation method and use thereof |
| 03/06/2013 | CN102949383A Anti-inflammatory and analgesic drug combination |
| 03/06/2013 | CN102949374A Medicinal composition containing zaltoprofen and capsule preparation method thereof |
| 03/06/2013 | CN102949358A Minodronic acid tablets and preparation method thereof |
| 03/06/2013 | CN102948760A Health-care product for increasing bone density and preparation method thereof |
| 03/06/2013 | CN102614120B Preparation method for sinomenine hydrochloride eye drops |
| 03/06/2013 | CN102488665B Febuxostat tablet and preparation method thereof |
| 03/06/2013 | CN102302752B Traumatic injury plaster |
| 03/06/2013 | CN102302616B Cataplasm for treating knee osteoarthritis and preparation method thereof |
| 03/06/2013 | CN102293923B Application of Tibetan medicinal composition to preparation of medicament for preventing and treating osteoporosis |
| 03/06/2013 | CN102286346B Crocodile bone wine and production method thereof |
| 03/06/2013 | CN102283917B Deer bone medicated liquor for treating fracture |
| 03/06/2013 | CN102274460B Tibetan medicine aerosol for treating acute and chronic sprain/contusion, rheumatism and rheumatoid disease |
| 03/06/2013 | CN102266542B Ointment patch for treating hyperosteogeny and preparation method thereof |
| 03/06/2013 | CN102258598B Medicine prepared by active part of pawpaw, its preparation method and its application |
| 03/06/2013 | CN102218058B Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy |
| 03/06/2013 | CN102204954B Zideng tablet and preparation method thereof |
| 03/06/2013 | CN102198246B Chinese medicinal preparation for treating bone diseases |
| 03/06/2013 | CN102188527B Chinese medicinal skin externally-stuck bone setting medicament |
| 03/06/2013 | CN102068447B Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 03/06/2013 | CN102058564B Zaltoprofen slow-release/controlled-release preparation and preparation method thereof |
| 03/06/2013 | CN101926815B Paeoniflorin and glycyrrhetinic acid composition and preparation method and application thereof |
| 03/06/2013 | CN101098859B Pyrimidinone compound, preparation and application thereof |
| 03/05/2013 | US8389551 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 03/05/2013 | US8389546 Compounds for modulating TRPV3 function |
| 03/05/2013 | US8389484 Methods for targeting RNA molecules |
| 03/05/2013 | US8388977 Diagnosis of macrophage mediated disease |
| 03/05/2013 | US8388947 Maintenance and propagation of mesenchymal stem cells |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | CA2427161C Use of bisphosphonates for pain treatment |
| 02/28/2013 | WO2013027801A1 Fused heterocyclic derivative and pharmaceutical use thereof |
| 02/28/2013 | WO2013027658A1 Cartilage/bone destruction suppressor |
| 02/28/2013 | WO2013026089A1 Peptides for use in the treatment of il-1 related diseases and conditions |
| 02/28/2013 | WO2011115527A8 New biologically active compound n-[3-(4-nitrophenylamino)-indol-2-ylmethylene]aminoguanidine hydrochloride with anti-inflammatory activity |
| 02/28/2013 | US20130053419 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
| 02/28/2013 | US20130053416 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053402 Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/28/2013 | US20130053398 Modulators of fatty acid amide hydrolase |
| 02/28/2013 | US20130053397 Indoles |
| 02/28/2013 | US20130053395 Pyrazolopyridine kinase inhibitors |
| 02/28/2013 | US20130053394 Pyrazolopyrimidine kinase inhibitors |
| 02/28/2013 | US20130053393 Methods and compositions for treating peripheral vascular disease |
| 02/28/2013 | US20130053388 Pyrazolopyrazine kinase inhibitors |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053379 4-aryl-2-anilino-pyrimidines |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3 |
| 02/28/2013 | US20130053354 Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative |
| 02/28/2013 | US20130053346 Pyrimido-pyridazinone compounds and methods of use thereof |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053343 Compounds and methods for inhibiting serotonin synthesis |
| 02/28/2013 | US20130053339 Synergistic phytochemical composition and a process for preparation thereof |
| 02/28/2013 | US20130053323 Methods and use related to humanin and humanin-like peptides |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130052279 Reverse micelle system comprising metal ions and use thereof |
| 02/28/2013 | US20130052274 Nutritional compositions including exogenous vitamin k2 |
| 02/28/2013 | US20130052271 Compositions and Methods for Treating Pain |
| 02/28/2013 | US20130052267 Methods of Inducing Tissue Regeneration |
| 02/28/2013 | US20130052254 System and method for a piezoelectric scaffold for tissue growth and repair |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052203 In vivo screening models for treatment of qc-related disorders |
| 02/28/2013 | US20130052199 Molecular Determinants of Myeloma Bone Disease and Uses Thereof |
| 02/28/2013 | US20130052197 Novel anti-cd98 antibody and use thereof |
| 02/28/2013 | US20130052195 Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use Thereof |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052155 Compositions and Methods for Treating a Disorder or Defect in Soft Tissue |
| 02/27/2013 | EP2562186A1 Antigen binding proteins that bind PAR-2 |
| 02/27/2013 | EP2561883A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561882A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561881A2 Novel vascular endothelial growth factor expression inhibitors |
| 02/27/2013 | EP2561877A1 A Composition containing a Bisphosphonic Acid in combination with Vitamin D |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2560972A2 Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | EP2560642A2 Treatment of gout |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102947326A Ccn3 peptides and analogs thereof for therapeutic use |
| 02/27/2013 | CN102947306A 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as SYK inhibitors |
| 02/27/2013 | CN102947305A Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | CN102947302A Triazolo [4, 5 - b] pyridin derivatives |
| 02/27/2013 | CN102946908A Inhibitor of expression of dominant allele |
| 02/27/2013 | CN102946904A Arthritis treatment |
| 02/27/2013 | CN102946884A Composition for preventing or treating osteoporosis, and manufacturing method therefor |
| 02/27/2013 | CN102942616A Peptide capable of binding to immunoglobulin |